Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
Lonnemann
G
G
Abteilung Nephrologie, Medizinische Hochschule Hannover, Germany.
Schindler
R
R
D001672:Biocompatible Materials; D002482:Cellulose / Q000031:analogs & derivatives*; D016207:Cytokines / Q000378:metabolism*; D004926:Escherichia coli / Q000254:growth & development; D004927:Escherichia coli Infections / Q000209:etiology; D015312:Hemodialysis Solutions; D006801:Humans; D066298:In Vitro Techniques; D007676:Kidney Failure, Chronic / Q000276:immunology / Q000628:therapy; D007688:Kidneys, Artificial; D008567:Membranes, Artificial; D009504:Neutrophils / Q000276:immunology; D010539:Permeability; D011108:Polymers; D011552:Pseudomonas Infections / Q000209:etiology; D011550:Pseudomonas aeruginosa / Q000254:growth & development; D011749:Pyrogens / Q000493:pharmacokinetics*; D006435:Renal Dialysis; D013450:Sulfones; D014462:Ultrafiltration; D014871:Water Microbiology
D001672:Biocompatible Materials; D016207:Cytokines; D015312:Hemodialysis Solutions; D008567:Membranes, Artificial; D011108:Polymers; D011749:Pyrogens; D013450:Sulfones; C017662:polysulfone P 1700; D002482:Cellulose; C009865:cuprammonium cellulose